Access to anti-retroviral drugs, female in Angola
Angola: Access to anti-retroviral drugs, female was 50.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Angola, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Angola is 50.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 6.4% on the previous year and up 100.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Angola peaked at 50.0% in 2024 and was at its lowest, 0.0%, in 2000.
Angola ranks 122nd of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Angola, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 2.0% | — |
| 2007 | 3.0% | +50.0% |
| 2008 | 5.0% | +66.7% |
| 2009 | 7.0% | +40.0% |
| 2010 | 9.0% | +28.6% |
| 2011 | 10.0% | +11.1% |
| 2012 | 11.0% | +10.0% |
| 2013 | 19.0% | +72.7% |
| 2014 | 25.0% | +31.6% |
| 2015 | 26.0% | +4.0% |
| 2016 | 24.0% | -7.7% |
| 2017 | 25.0% | +4.2% |
| 2018 | 27.0% | +8.0% |
| 2019 | 30.0% | +11.1% |
| 2020 | 35.0% | +16.7% |
| 2021 | 40.0% | +14.3% |
| 2022 | 43.0% | +7.5% |
| 2023 | 47.0% | +9.3% |
| 2024 | 50.0% | +6.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 1.7% | 0.0% | 7.0% | 10 |
| 2010s | 20.6% | 9.0% | 30.0% | 10 |
| 2020s | 43.0% | 35.0% | 50.0% | 5 |
Countries ranked near Angola
More gender data for Angola
- Child population (UN estimates and projections) 19,236 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 2.13 % change on previous year (2030)
- Population 25,925 (2030)
- Working-age population (UN estimates and projections) 25,925 (2030)
- Population (UN estimates and projections), annual growth rate 3.47 % change on previous year (2030)
- Age population, age 00, female, interpolated 676,513 (2025)
- Age population, age 00, male, interpolated 689,235 (2025)
- Age population, age 01, female, interpolated 656,125 (2025)
- Age population, age 01, male, interpolated 667,064 (2025)
- Age population, age 02, female, interpolated 640,250 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Angola?
- Access to anti-retroviral drugs, female in Angola was 50.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Angola?
- The highest recorded value was 50.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Angola?
- The lowest recorded value was 0.0% in 2000.
- How does Angola rank for access to anti-retroviral drugs, female?
- Angola ranks 122nd out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Angola?
- Over the last ten years it is up 100.0%. The long-run trend across the full record is volatile.
- Where does this Angola data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.